PTCG
IBB icon

Pring Turner Capital Group’s iShares Biotechnology ETF IBB Stock Holding History

Pring Turner Capital Group’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-300
Closed -$23K – 100
2013
Q4 		$23K Buy
+300
New +$21.3K 0.02% 129

Other funds holding IBB

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return
CM
Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return
BTS
BB&T Securities Richmond, Virginia $10.9B AUM 5.31% 1-Year Est. Return

Pring Turner Capital Group's IBB Position: Q1 2014 in Review

Pring Turner Capital Group sold out of iShares Biotechnology ETF (IBB) in Q1 2014, closing a stake of 300 shares — an estimated $23K sold.

Pring Turner Capital Group first reported a position in IBB in Q4 2013 and held it in 1 quarter. The position peaked at $23K in Q4 2013. 288 funds tracked by Wall St. Rank hold IBB as of Q1 2014.

  • Pring Turner Capital Group reported no remaining iShares Biotechnology ETF position as of Q1 2014 after selling out during the quarter.
  • Pring Turner Capital Group sold 300 iShares Biotechnology ETF shares in Q1 2014, an estimated $23K.
  • Pring Turner Capital Group first reported a position in iShares Biotechnology ETF in Q4 2013 and held it in 1 quarter.
  • Pring Turner Capital Group's iShares Biotechnology ETF position peaked at $23K in Q4 2013.
  • 288 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2014.

Based on Pring Turner Capital Group's 13F filing for Q1 2014, filed 14 May 2014.